This testimony addresses critical legislative proposals to support patients with rare diseases, including H.R. 6705, the Effective Screening and Testing for Tuberculosis Act, and H.R. 7188, the Shandra Eisenga Human Cell and Tissue Product Safety Act.

The Board of Governors recently voted to dissolve two AATB Committees, the Program Committee and Communications Committee.

AATB is excited to introduce a revolutionary initiative that is set to transform the efficiency and effectiveness of tissue recovery operations for all our valued members.

On January 5, CDC published the article titled “Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells – United States, 2023” in Morbidity and Mortality Weekly Report.

AATB is pleased to announce the first draft of the 15th edition of Standards for Tissue Banking.

We are aware of the Last Week Tonight with John Oliver segment that aired over the weekend, discussing organ and whole-body donation.

The Board of Governors has taken action on the recommendations put forth by the Accreditation Com

The three skin substitute LCDs/LCAs, entitled "Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers," and proposed by CGS Administrators, LLC, Novitas Solutions, Inc., and First Coast Service Options, Inc. will not go into effect on October 1, 2023, as previously announced.

Please join us in congratulating the newly elected Officers and At-Large Members of the Board of